These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7503085)

  • 1. Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations.
    Abu-Shakra M; Gladman DD; Urowitz MB; Farewell V
    Am J Med; 1995 Dec; 99(6):624-8. PubMed ID: 7503085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations. The SLE Study Group.
    Sachse C; Lüthke K; Hartung K; Fricke M; Liedvogel B; Kalden JR; Peter HH; Lakomek HJ; Henkel E; Deicher H
    Rheumatol Int; 1995; 15(1):23-9. PubMed ID: 7652462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?
    Gómez-Puerta JA; Martín H; Amigo MC; Aguirre MA; Camps MT; Cuadrado MJ; Hughes GRV; Khamashta MA
    Medicine (Baltimore); 2005 Jul; 84(4):225-230. PubMed ID: 16010207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-oxidized low-density-lipoprotein (OxLDL) antibodies in systemic lupus erythematosus with and without antiphospholipid syndrome.
    Hayem G; Nicaise-Roland P; Palazzo E; de Bandt M; Tubach F; Weber M; Meyer O
    Lupus; 2001; 10(5):346-51. PubMed ID: 11403265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome?
    Miret C; Cervera R; Reverter JC; García-Carrasco M; Ramos M; Mollà M; Font J; Ingelmo M
    Clin Exp Rheumatol; 1997; 15(5):541-4. PubMed ID: 9307863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations.
    Basiri Z; Gholyaf M; Faridnia M; Nadi E; Bairanvand M
    Acta Med Iran; 2013; 51(1):35-40. PubMed ID: 23456582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J; Swadzba J; Motyl A; Iwaniec T
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of anticardiolipin and anti-beta2-glycoprotein I antibodies.
    Obermoser G; Bitterlich W; Kunz F; Sepp NT
    Int Arch Allergy Immunol; 2004 Oct; 135(2):148-53. PubMed ID: 15345914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal anticardiolipin antibodies derived from mice with experimental lupus erythematosus: characterization and the induction of a secondary antiphospholipid syndrome.
    Sthoeger ZM; Tartakovsky B; Bentwich Z; Mozes E
    J Clin Immunol; 1993 Mar; 13(2):127-38. PubMed ID: 7686561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticardiolipin antibodies in patients with systemic lupus erythematosus].
    Petrović R; Petrović M; Novicić-Sasić D; Damjanov N
    Srp Arh Celok Lek; 1994; 122 Suppl 1():98-100. PubMed ID: 18173204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
    Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
    Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.
    Love PE; Santoro SA
    Ann Intern Med; 1990 May; 112(9):682-98. PubMed ID: 2110431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of antimitochondrial antibodies type 5 and anti-beta 2 glycoprotein I antibodies in the antiphospholipid syndrome.
    Laperche S; Abuaf N; Meyer O; Carsique R; Deschamps A; Rajoely B; Johanet C; Homberg JC
    J Rheumatol; 1994 Sep; 21(9):1678-83. PubMed ID: 7799349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Samarkos M; Davies KA; Gordon C; Loizou S
    Clin Rheumatol; 2006 Mar; 25(2):199-204. PubMed ID: 16091839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.